Clinical studies recruiting near Varna

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · UMHAT Multiprofile Hospital for Active Treatment Sveta Marin · AbbVie · NCT04928846 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · University Multiprofile Hospital for Active Treatment "Sveta · Takeda · NCT06499285 A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Livi
Phase 2 · UMHAT Sveta Marina EAD, Clinic of Internal Diseases · Novo Nordisk A/S · NCT06717698 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06830044 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · MHAT Sveta Marina EAD · Bayer · NCT06452277 A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D
Phase 2 · Site Number - 5602 · Immunovant Sciences GmbH · NCT07018323 Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Phase 2 · SHATC Cardiolife, Invasive Cardiology · Acesion Pharma · NCT07267949 Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrom
Phase 2 · Multiprofile Hospital for Active Treatment Sveta Marina EAD · RECORDATI GROUP · NCT03708900 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Medical Center Researchexpert OOD · Hoffmann-La Roche · NCT05878769 New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye
Phase 4 · Group Practice Outpatient Clinic for Specialized Medical · Laboratoires Thea · NCT06903741 A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Th
Phase 3 · UMHAT Multiprofile Hospital for Active Treatment Sveta Marin · AbbVie · NCT05995353 A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Medical Centre Pratia Clinic EOOD · Apollo Therapeutics Ltd · NCT07599813 A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Phase 3 · Local Institution - 1102 · Bristol-Myers Squibb · NCT06937229 Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Phase 2 · Medical Centre Pratia Clinic EOOD - Varna_Site 100001 · Chiesi Farmaceutici S.p.A. · NCT07301736 A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Phase 3 · UMHAT Sveta Marina EAD, First Pediatric Clinic · Novo Nordisk A/S · NCT07253285 Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Wh
Phase 3 · Kailera Clinical Site · Kailera · NCT07284875 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Medical Center Mladost · Bristol-Myers Squibb · NCT07011732 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966 A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe
Phase 3 · MHAT 'Sv. Anna - Varna' AD · Boehringer Ingelheim · NCT07361302 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Phase 2 · UMHAT Multiprofile Hospital for Active Treatment Sveta Marin · AbbVie · NCT06548542 A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Phase 3 · Multiprofile Hospital for Active Treatment Sveta Anna - Varn · Genexine, Inc. · NCT06466785 Remibrutinib Open Label Roll-over Post-trial Access Protocol
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07456891 A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
Phase 1/Phase 2 · Haelan Care 4 Medical Center EOOD · ImmunAbs Inc. · NCT07250750 Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer
Phase N/A · Research Site · AstraZeneca · NCT06727227 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Dia
Phase 3 · Research Site · AstraZeneca · NCT07662135

Look up another city

Look up another condition